Articles
Executive perspectives: Deepak Khanna

Executive perspectives: Deepak Khanna

Paul Tunnah speaks with Deepak Khanna, Managing Director at MSD, about his recent appointment as President of the ABPI and the unique experience he brings to the role. Good health is something most people take for granted, but behind-the-scenes, the pharmaceutical industry has played, and continues to play...

Articles
What about the clinical research sites in Latin America?

What about the clinical research sites in Latin America?

Valentina Jaramillo provides an overview of the current environment of clinical research sites in Latin America. There have been discussions for a while now on the importance of developing countries in clinical research and I think it is pretty clear by now that all developing...

Articles
Why pharma clinical development must go beyond its means

Why pharma clinical development must go beyond its means

Chris Fidyk takes a look at the history of the pharmaceutical industry, with regards to clinical trials legislation and how it has evolved over the years. As the American healthcare system marches slowly, but steadily, away from its fee-for-service roots towards a fee-for-value future...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more